Related Experiment Video
Updated: Feb 18, 2026
07:16
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
14.3K
Classics in chemical neuroscience: diazepam (valium)
Nicholas E Calcaterra1, James C Barrow
1Department of Pharmacology, Johns Hopkins University , Baltimore, Maryland 21205, United States.
ACS Chemical Neuroscience
|February 21, 2014
Summary
Diazepam, a groundbreaking medication from the 1950s, remains a benchmark for treating central nervous system disorders like anxiety and epilepsy due to its efficacy and safety.
Area of Science:
- Neuroscience
- Pharmacology
- Drug Discovery
Background:
- Diazepam (Valium) emerged during the 1950s psychopharmacological revolution.
- It established new standards for drug potency, onset of action, and safety in treating CNS disorders.
- Its efficacy in anxiety and epilepsy management is well-documented.
Purpose of the Study:
- To review the historical and scientific legacy of diazepam in chemical neuroscience.
- To provide a comprehensive overview of diazepam's multifaceted aspects.
- To examine its impact on modern pharmacotherapy.
Main Methods:
- Literature review focusing on diazepam.
- Analysis of synthesis pathways and pharmacological mechanisms.
- Examination of clinical data, adverse events, and regulatory status.
Main Results:
- Diazepam's significant contributions to neuroscience and psychopharmacology.
- Detailed insights into its synthesis, metabolism, and therapeutic applications.
- Discussion of its safety profile, dependence potential, and regulatory landscape.
Conclusions:
- Diazepam's enduring impact on the treatment of CNS disorders.
- Its role as a foundational drug in neuroscience and pharmacotherapy.
- The importance of understanding its complete profile, from synthesis to clinical use and regulation.
Related Concept Videos
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
972
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
972
01:14CNS Depressants: Barbiturates and Benzodiazepines
1.4K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.4K
01:27CNS Depressants: Alcohol and Nicotine
1.4K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.4K
01:23Sedatives and Hypnotics: Overview
1.6K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.6K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
633
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
633
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
2.6K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
2.6K